Sooma
Helsinki, FI · 4 known investors
Sooma Medical develops and manufactures transcranial direct current stimulation (tDCS) devices for treating major depressive disorder, fibromyalgia, and chronic neuropathic pain without medication. The company serves clinics, hospitals, and universities globally through neuromodulation technology approved for clinical use and research.
Founders & leadership
TN
Tuomas NeuvonenCTO
AH
Andreas HartlepCEO
MN
Mika NikanderCOO
Investors · 4
In the news
- Sooma Medical raises $5.5M for depression-treating neuromod | EstVCAestvca.ee · 2024
- Sooma from Finland secures €5M for Neurological and Psychiatric Disorder Treatments - FoundersTodayfounderstoday.news · 2024
- Sooma raises €5m to develop alternative treatment for depression | Siftedsifted.eu · 2024
- Sooma Medical Raises €1.25M in Funding - FinSMEsfinsmes.com · 2019